跳至主要内容
临床试验/EUCTR2010-021396-81-SE
EUCTR2010-021396-81-SE进行中(未招募)不适用

European Low and Intermediate Risk Neuroblastoma - LINES

INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA0 个研究点目标入组 685 人开始时间: 2014年12月17日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
685

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • BASED ON AGE, STAGE, BIOLOGICAL CHARACTERISTICS AND PRESENCE OF SEVERE SYMPTOMS. AS THERE ARE 3 ARMS OF TREATMENT, THE CRITERIA ARE DIFFERENT IN EACH. SEE PROTOCOL
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 685
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • BASED ON AGE, STAGE, BIOLOGICAL CHARACTERISTICS AND PRESENCE OF SEVERE SYMPTOMS. AS THERE ARE 3 ARMS OF TREATMENT, THE CRITERIA ARE DIFFERENT IN EACH. SEE PROTOCOL

研究者

发起方
INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA

相似试验